Half Year 2024 Dbv Technologies SA Earnings Call Transcript - Thomson StreetEvents

Half Year 2024 Dbv Technologies SA Earnings Call Transcript

Half Year 2024 Dbv Technologies SA Earnings Call Transcript - Thomson StreetEvents
Half Year 2024 Dbv Technologies SA Earnings Call Transcript
Published Jul 30, 2024
8 pages (4328 words) — Published Jul 30, 2024
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of DBV.PA earnings conference call or presentation 30-Jul-24 9:30pm GMT

  
Brief Excerpt:

...Operator Welcome to the DBV second quarter financial results and business update conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Katie Matthews, Investor Relations. Please go ahead. Katie Matthews ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
DBV Technologies SA
Ticker
DBV.PA
Time
9:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Jon Wolleben - Citizens JMP - Analyst : Hey, good afternoon. Thanks for the update and taking the questions. Maybe just one quick clarification on the label-in, label-out, and then I have some follow-ups on that. When you say patch wear time experience, do you mean how long the kids are wearing the patch or the experience they have while wearing the patch or an interplay between those two concepts?

Question: Jon Wolleben - Citizens JMP - Analyst : Yeah. Well, does that make it harder to quantify them, though, than a simple number of hours worn?

Question: Jon Wolleben - Citizens JMP - Analyst : Got it. Okay. And then you guys said there's an association between a robust clinical efficacy response. I'm wondering if you could put some parameters around what you define as a robust response, and then what percentage of the EPITOPE patients were label and label out based on this criteria?

Question: Jon Wolleben - Citizens JMP - Analyst : Fair enough.

Question: Jon Wolleben - Citizens JMP - Analyst : Got it. And one last one for me. Update on COMFORT Children, you guys don't have any expectations for feedback timing there it doesn't seem. Wondering, do you think that any progress with COMFORT Toddlers would help with COMFORT Children, or are there different issues and feedback from FDA there.

Question: Jon Wolleben - Citizens JMP - Analyst : Got it. Okay. Thanks again for taking the questions.

Table Of Contents

Dbv Technologies SA Corporate Call Transcript – 2025-12-16 – US$ 54.00 – Edited Transcript of DBV.PA conference call or presentation 16-Dec-25 10:00pm GMT

Dbv Technologies SA Corporate Call Transcript – 2025-06-25 – US$ 54.00 – Edited Transcript of DBV.PA conference call or presentation 25-Jun-25 9:00pm GMT

Dbv Technologies SA Investor Conference Call Transcript – 2025-03-31 – US$ 54.00 – Edited Transcript of DBV.PA conference call or presentation 31-Mar-25 9:00pm GMT

Dbv Technologies SA Corporate Call Transcript – 2025-01-08 – US$ 54.00 – Edited Transcript of DBV.PA conference call or presentation 8-Jan-25 4:00pm GMT

Dbv Technologies SA Conference Call Transcript – 2024-10-22 – US$ 54.00 – Edited Transcript of DBV.PA conference call or presentation 22-Oct-24 9:00pm GMT

Dbv Technologies SA to Discuss the EPOPEX Data Call Transcript – 2023-11-09 – US$ 54.00 – Edited Transcript of DBV.PA conference call or presentation 9-Nov-23 10:00pm GMT

Dbv Technologies SA Q3 2023 Earnings Call Transcript – 2023-10-31 – US$ 54.00 – Edited Transcript of DBV.PA earnings conference call or presentation 31-Oct-23 9:00pm GMT

Half Year 2023 Dbv Technologies SA Earnings Call Transcript – 2023-07-31 – US$ 54.00 – Edited Transcript of DBV.PA earnings conference call or presentation 31-Jul-23 9:00pm GMT

Dbv Technologies SA at Goldman Sachs Healthcare Conference Transcript – 2023-06-14 – US$ 54.00 – Edited Transcript of DBV.PA presentation 14-Jun-23 5:00pm GMT

Dbv Technologies SA at JMP Securities Life Sciences Conference Transcript – 2023-05-15 – US$ 54.00 – Edited Transcript of DBV.PA presentation 15-May-23 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Half Year 2024 Dbv Technologies SA Earnings Call Transcript" Jul 30, 2024. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Half-Year-2024-Dbv-Technologies-SA-Earnings-Call-T16069798>
  
APA:
Thomson StreetEvents. (2024). Half Year 2024 Dbv Technologies SA Earnings Call Transcript Jul 30, 2024. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Half-Year-2024-Dbv-Technologies-SA-Earnings-Call-T16069798>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.